Form 4: NeuroMetrix Director Joshua Horowitz Reports Stock Transactions

Director Joshua Horowitz of NeuroMetrix, Inc. reports the acquisition of common stock and restricted stock units, along with a correction to a previous filing.

Summary

• Joshua Horowitz, a director at NeuroMetrix, Inc., reported acquiring 369 shares of common stock and 6,000 restricted stock units (RSUs) on February 3, 2025.
• The RSUs vest immediately upon issuance and each represents the right to receive one share of common stock.
• These RSUs were granted as compensation for his services as a non-employee director.
• The filing also corrects an error in the total number of RSUs reported in a previous filing on April 30, 2024.
• Horowitz also has indirect beneficial ownership of 60,500 shares through Palm Management (US) LLC, where he is a portfolio manager and special limited partner.

Sentiment

Score: 7

Explanation: The document is a routine filing of stock transactions by a director, which is neither positive nor negative. The correction of a previous error is a positive sign of transparency.

Positives

• The acquisition of RSUs indicates continued alignment of director interests with the company's performance.
• The correction of the previous filing demonstrates transparency and attention to detail.

Industry Context

This is a standard SEC Form 4 filing, which is common for company insiders reporting changes in their beneficial ownership of company stock. It is a routine part of corporate governance and transparency.

Comparison to Industry Standards

• The reporting of stock transactions by directors is a standard practice across all publicly traded companies.
• The use of RSUs as compensation for non-employee directors is also a common practice.
• The correction of a previous filing is not unusual and demonstrates adherence to regulatory requirements.

Stakeholder Impact

• The stock transactions by a director may have a minor impact on shareholder sentiment.
• The correction of the previous filing enhances transparency for all stakeholders.

Key Dates

Keywords

NeuroMetrix, Director, Joshua Horowitz, Stock Transactions, Restricted Stock Units, RSUs, Beneficial Ownership, Form 4, SEC Filing